Monroe-Sheridan Foreign Law Office represented Reborna Biosciences, Inc. in its research collaboration with Biogen Inc. The research collaboration was publicly announced on April 30, 2021.
The press release announcing the research collaboration is available here: https://rebornabiosciences.com/en/news/1023
From the press release:
“Biogen is a leading company in the field of neurological diseases, and we are very pleased that our drug discovery technology has been well-received by the organization. We hope to continue this collaboration with Biogen with the goal of potentially bringing medicines to people living with central nervous system disease,” said Koji Fuji, Ph.D., Chief Executive Officer at Reborna.
Note: Disclosure of previous engagements is made with the consent of the client.